Results 151 to 160 of about 1,510 (191)

P314 Pharmacokinetics of olopatadine administered as GSP301 nasal spray versus olopatadine monotherapy

Annals of Allergy, Asthma & Immunology, 2016
P. Patel, A. Salapatek, P. Agarwal, R. Talluri, S. Tantry   +4 more
openaire   +1 more source

Biomimetic Contact Lenses Eluting Olopatadine for Allergic Conjunctivitis

Acta Biomaterialia, 2016
Angel Concheiro, Clara González-Chomón
exaly  

Cefcapene-pivoxil/heparinoid/olopatadine

Reactions Weekly, 2023
openaire   +1 more source

Clinical Efficacy of Olopatadine vs Epinastine Ophthalmic Solution in the Conjunctival Allergen Challenge Model

Current Medical Research and Opinion, 2004
David B Granet
exaly  

Olopatadine 0.2% Ophthalmic Solution: The First Ophthalmic Antiallergy Agent With Once-Daily Dosing

Expert Opinion on Drug Metabolism and Toxicology, 2008
Mark B Abelson
exaly  

Olopatadine.

2011
openaire   +1 more source

PROCESS FOR THE PREPARATION OF OLOPATADINE

2010
CASTELLIN ANDREA, FERRARI CLARK, GALVAGNI MARCO   +2 more
openaire   +11 more sources

Olopatadine (ophthalmic solution)

2017
openaire   +2 more sources

P-Glycoprotein Limits the Brain Penetration of Olopatadine Hydrochloride, H1-Receptor Antagonist

Drug Metabolism and Pharmacokinetics, 2008
Nobuo Kubo
exaly  

Olopatadine

2016
openaire   +1 more source